Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Synthorx, Inc. News

France's Sanofi to Buy Cancer-Drug Specialist Synthorx for $68-Share, or $2.5 Billion

The deal price is nearly triple Synthorx's Friday closing price above $25. One of Sanofi's goals is to build its oncology franchise, the CEO said in a statement.

Merck & Co. Acquires Cancer Drug Specialist ArQule For $2.7 Billion

ArQule shares surge after the cancer drug specialists agreed to a $2.7 billion takeover bid from Merck & Co.

Jim Cramer Reacts to Thor Industries Earnings

Jim Cramer said millennials played a big part in Thor Industries' colossal earnings beat.

Thor Industries Drops Double Digits on Mixed Earnings

Thor Industries beat FactSet's expectations but missed Zacks bottom-line estimates.

Oil, Yellen and world gdp growth: How to trade the week ahead

Conditions seem ripe for continued upward momentum in stocks, as long as the Federal Reserve or unexpected shocks don't get in the way.

Breaking News

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.